Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Intermittent fasting is generally not recommended during tirzepatide therapy
Mechanism: Injected subcutaneously (under the skin) into the abdomen, thigh, or upper arm
Patients must disclose diabetes status, heart conditions, thyroid history, pancreatitis, kidney function, eating disorders, and pregnancy status-all variables that influence whether semaglutide is safe to prescribe
The starting dose is typically low and is titrated up based on individual tolerance and weight loss response
In February 2026, Eli Lily and Company notified that the U.S
US$ 20.50
US$ 27.50
US$ 28.59
